Which company is the original manufacturer of Platinib? Are there any generics?
Platinib, widely known by the trade name Pujihua, is a treatment drug for lung and thyroid cancer that targetsRET gene mutations. Its core mechanism is to inhibit the phosphorylation process of the receptor tyrosine kinase RET and its downstream molecules, thereby effectively controlling the growth of cancer cells carrying RET gene mutations and opening up new treatment paths for many cancer patients.
The original drug Platinib is a drug developed and produced by Blueprint Medicines. This internationally renowned biopharmaceutical company has been committed to developing personalized treatment solutions for cancer. As a blockbuster product developed by it, Platinib has verified its excellent efficacy and safety through multiple rigorous clinical studies, and has been widely recognized and marketed around the world. In China, the original drug has also been successfully approved by the State Food and Drug Administration, and patients can purchase it with peace of mind through regular channels.

At the same time, generic versions of platinib have received widespread attention from the market. Currently, Lucius Pharmaceuticals in Laos has launched a generic version of Platinib and has won a good reputation in the market. This drug has been officially approved by the Lao government and its quality is guaranteed. However, considering that most generic drugs need to be purchased overseas, patients are advised to be cautious when choosing to purchase them. They can consult reputable overseas medical institutions or go directly to Laos to purchase.
Whether it is an original drug or a generic drug, Platinib belongs to the category of prescription drugs and must be used under the guidance of a professional doctor. Patients should pay close attention to their physical condition while taking the medication. If they feel any discomfort, they should contact their doctor immediately to ensure the safety and effectiveness of the medication process.
In summary, whether in the field of original drugs or generic drugs,Blueprint Medicines and Laos Lucius Pharmaceuticals have demonstrated excellent credibility and strength, and jointly provide cancer patients with more diverse and reliable treatment options.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)